The effect of treatment with a non-ionic surfactant vesicular formulation of sodium stibogluconate on host immune responses and serum metabolites in a murine model of <i>Leishmania donovani</i>.

Front Immunol · 2025 · PMC12528065 · PMID 41112308

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although not statistically significant, SSG-NIV treatment also showed a trend for elevated levels of IL-12p70 and IL-4, two other protective cytokines in VL ( Figures 2B, C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

The effect of treatment with a non-ionic surfactant vesicular formulation of sodium stibogluconate on host immune responses and serum metabolites in a murine model of &lt;i&gt;Leishmania donovani&lt;/i&gt;.

The sentences

The effect of treatment with a non-ionic surfactant vesicular formulation of sodium stibogluconate on host immune responses and serum metabolites in a murine model of <i>Leishmania donovani</i>.